Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antivirals
Research
Protease inhibitor outperforms Paxlovid protecting lungs of mice
An oral drug developed by Stanford University researchers may be superior to Pfizer’s Paxlovid at reducing the severity of COVID-19, at least in mice.
Helen Floersh
Mar 14, 2024 6:30am
COVID-19 Moonshot pioneers explain success of open innovation
Nov 27, 2023 10:00am
GSK gives early look at HIV bNAb's power
Oct 25, 2022 10:00am
New antiviral class could halt treatment-resistant viruses
May 16, 2022 3:10pm
AbbVie, Scripps prep for endemic COVID-19 with antiviral collab
Mar 15, 2022 11:29am